Project Grant HT94252310378

Award Date 6/1/23
Completion Date 5/31/25
Dollars Obligated $239K
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Charlottesville, VA, USA
Similar Awards
The University of Virginia will receive $748,422 under a three-year Project Grant award from the Department of the Army Medical Command. The award is funded through the Military Medical Research and Development program (CFDA 12.420). The University will quantify the relationship between brain biomechanics and head exposures relevant to warfighters. Insights gained from this research aim to guide the development of future injury prevention technologies. Specifically, the University seeks to...
This Project Grant from the Defense Health Agency provides $745,381 to Virginia Commonwealth University from June 1, 2023 through May 31, 2026 to support research on "POST-TRAUMATIC EPILEPTOGENESIS: ROLE OF NEOCORTICAL-HIPPOCAMPAL INTERACTIONS" under the Military Medical Research and Development program (CFDA 12.420). VCU will conduct this research to advance the program's goals of transforming military and public healthcare through innovative biomedical research solutions. Subawards...
This $847,875 federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) supports research at the University of Virginia aimed at understanding the role of the Schwann cell tumor microenvironment in the development of neurofibromas. The project will take place over 3 years from September 2025 to August 2028. The research seeks to advance scientific understanding of this medical condition relevant to...
The Defense Health Agency awarded Vanderbilt University Medical Center a $1,567,553 Project Grant under the Military Medical Research and Development federal grant program (CFDA 12.420). The two-year grant will fund research to optimize therapeutic control of epilepsy in tuberous sclerosis complex using a novel biosensor. Per the award description, following preclinical and pilot human studies, Vanderbilt predicts that larger clinical trials will demonstrate improved control of epilepsy using...
The Department of the Army Medical Command awarded The Washington University $781,381 under the Military Medical Research and Development federal grant program (CFDA 12.420) for the period of May 1, 2022 through April 30, 2025. The funding supports the university's project "Mechanisms of Sleep-Seizure Interactions in Tuberous Sclerosis Complex," which will investigate medical solutions for seizures associated with sleep in those suffering from tuberous sclerosis complex. Through basic,...
Virginia Commonwealth University was awarded a $749,446 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from September 2023 through September 2026 to develop a novel TNF inhibitor to improve outcomes in a mouse model of traumatic brain injury. Through supporting innovative biomedical research, the Military Medical Research and Development program aims to transform military and...
This Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $3,208,546.00 to the Rector & Visitors of the University of Virginia (University of Virginia) to expand the Generalized Blast Exposure Value Tool. The purpose of this project is to determine cumulative blast exposure thresholds in military populations. The award term is from May 15, 2025 to May 14, 2029. The University of Virginia, a...
The University of Virginia (UVA) received a $888,251 Project Grant award from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) to conduct research comparing the effectiveness of a hybrid versus lecture-based training approach for improving first responder competence in autism response. The project, titled "AUTISM RESPONSE PROTOCOL: COMPARING THE EFFECTIVENESS OF A HYBRID VS LECTURE-BASED TRAINING ON AUTISM COMPETENCE IN FIRST RESPONDERS", will...
The University of Illinois received a $237,899 Project Grant from the U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) to conduct a research project titled "USING SENSORY PROCESSING TO IDENTIFY NEURAL CIRCUIT DEFICITS AND NOVEL TREATMENT STRATEGIES IN A RAT MODEL OF TSC". The research aims to transform healthcare for Service Members and the American public through innovative and impactful biomedical research. The award is for the project...
The Washington University received a $236,250 project grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant funding supports research from July 1, 2021 to June 30, 2023 to study the role of blood-brain barrier dysfunction in epilepsy associated with tuberous sclerosis complex. The Military Medical Research and Development program aims to transform military and public health through innovative biomedical...

The University of Virginia will receive $238,794 from the Defense Health Agency under a Project Grant award to investigate the mechanisms of seizure-induced death in TSC model mice. The research, to be conducted from June 2023 through May 2025 in Charlottesville, Virginia, aims to further the Military Medical Research and Development program's goal of transforming military and public health through innovative biomedical research solutions. Specifically, the grant will fund the university's work exploring medical solutions for seizures on the battlefield by studying how seizures cause death in mice models of tuberous sclerosis complex (TSC), a genetic disorder that often involves epilepsy. Insights from this research could help protect the health and safety of military service members and the general public.

Generated 1/23/24, 11:11 AM